Fatal Capecitabine Toxicity Despite Negative Standard DPYD Screening in a Patient With Breast Cancer Harboring Hypomorphic Variants: A Case Report
JCO Precision Oncology · 2026-11 · 10 (11)
DOI: 10.1200/po-26-00320 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCO Precision Oncology, 2026-11. Verfasst von Tommaso Lupo Landolfo und 13 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Landolfo, T. L., Nardin, S., Ruffilli, B., Isingrini, G., Taglialatela, I., D'Avanzo, F., Rossi, V., Mellone, S., Vita, N. D., Petrolini, V. M., Giordano, M., Vaschetto, R., Conte, B., & Gennari, A. (2026). Fatal Capecitabine Toxicity Despite Negative Standard DPYD Screening in a Patient With Breast Cancer Harboring Hypomorphic Variants: A Case Report. JCO Precision Oncology, 10(11). https://doi.org/10.1200/po-26-00320
Vancouver
Landolfo TL, Nardin S, Ruffilli B, Isingrini G, Taglialatela I, D'Avanzo F, et al. Fatal Capecitabine Toxicity Despite Negative Standard DPYD Screening in a Patient With Breast Cancer Harboring Hypomorphic Variants: A Case Report. JCO Precision Oncology. 2026;10(11). doi:10.1200/po-26-00320
BibTeX
@article{Landolfo2026,
author = {Landolfo, Tommaso Lupo and Nardin, Simone and Ruffilli, Beatrice and Isingrini, Giulia and Taglialatela, Ida and D'Avanzo, Francesca and Rossi, Valentina and Mellone, Simona and Vita, Nello De and Petrolini, Valeria Margherita and Giordano, Mara and Vaschetto, Rosanna and Conte, Benedetta and Gennari, Alessandra},
title = {Fatal Capecitabine Toxicity Despite Negative Standard DPYD Screening in a Patient With Breast Cancer Harboring Hypomorphic Variants: A Case Report},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {11},
doi = {10.1200/po-26-00320}
}
EUVIMED